Stocks REAX Financial statements
Financial statementsReal Brokerage Inc financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Real Brokerage Inc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 16.6 | 122 | 382 | 689 | 1,265 | 1,968 |
| Cost of revenue | 14.4 | 111 | 350 | 626 | 1,150 | 1,803 |
| Gross profit | 2.15 | 11.1 | 32 | 62.9 | 115 | 166 |
| Research and development | 0.41 | 3.98 | 4.87 | 7.36 | 12.2 | 17.4 |
| Selling and marketing | 38.6 | 57.5 | 82.4 | |||
| General and administrative | 42.9 | 61.1 | 74.4 | |||
| Operating expenses | 88.9 | 140 | 175 | |||
| Operating income | -2.65 | -11.3 | -19.7 | -26 | -25.2 | -9.25 |
| Interest expense | 0.14 | 0.66 | 1.17 | 0.62 | ||
| Interest income | 0.48 | 0.76 | ||||
| Other non-operating income | -0.59 | 0.5 | 1 | |||
| Pre-tax income | -26.5 | -8.81 | ||||
| Income tax | -0.74 | |||||
| Net income to minority interests | -0.24 | 0.29 | 0.09 | 0.04 | ||
| Net income | -3.62 | -11.7 | -20.6 | -27.5 | -26.5 | -8.11 |
| EBITDA | -24.9 | -23.8 | -7.32 | |||
| EPS, basic | -0.07 | -0.12 | -0.15 | -0.14 | -0.04 | |
| EPS, diluted | -0.04 | -0.07 | -0.12 | -0.15 | -0.14 | -0.04 |
| Shares, basic (weighted) | 178 | 191 | 220 | |||
| Shares, diluted (weighted) | 178 | 191 | 220 |
Balance sheet
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 21.3 | 29.1 | 18.3 | 14.7 | 23.4 | 33.2 |
| Short-term investments | 9.45 | 16.7 | ||||
| Receivables | 6.44 | 14.2 | 20.2 | |||
| Other current assets | 2.13 | 1.76 | 3.08 | |||
| Total current assets | 21.7 | 38.7 | 28.4 | 50.5 | 72.9 | 106 |
| Property, plant and equipment | 0.01 | 0.17 | 1.35 | 1.6 | 2.12 | 2.46 |
| Lease right-of-use assets | 0.19 | 0.11 | 0.07 | 0 | 0 | |
| Goodwill | 0 | 0.6 | 10.3 | 8.99 | 8.99 | 8.99 |
| Intangible assets | 0 | 0.45 | 3.71 | 3.44 | 2.58 | 4.16 |
| Long-term investments | 2.25 | |||||
| Total assets | 21.9 | 40 | 43.8 | 64.5 | 86.6 | 127 |
| Accounts payable | 0.82 | 0.05 | 0.47 | 0.57 | 1.37 | 1.16 |
| Accrued liabilities | 13.4 | 25.9 | 38.2 | |||
| Deferred revenue | 12.9 | 24.1 | 26.3 | |||
| Total current liabilities | 0.96 | 12.3 | 21.1 | 27.2 | 54.5 | 75.3 |
| Lease liabilities | 0.13 | 0.04 | ||||
| Total liabilities | 1.11 | 13 | 21.3 | 27.5 | 54.5 | 75.3 |
| Total debt | 0 | 0 | ||||
| Paid-in capital | 21.7 | 63.4 | 63.2 | 116 | 139 | 164 |
| Retained earnings | -18.4 | -30.1 | -50.7 | -78.2 | -105 | -113 |
| Treasury stock | -0.26 | -2.46 | ||||
| Other comprehensive income | -0.17 | 0.71 | 0.32 | |||
| Shareholders' equity | 5.98 | 27 | 22.2 | 36.9 | 32.1 | 51.7 |
| Minority interests | 14.8 | 0 | 0.26 | 0.21 | -0 | -0.09 |
| Total equity | 20.8 | 27 | 28.7 | 37.1 | 32.1 | 51.6 |
| Total liabilities and equity | 21.9 | 40 | 43.8 | 64.5 | 86.6 | 127 |
| Shares outstanding | 183 | 202 | 210 |
Cash flow statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | -3.62 | -11.7 | -20.3 | -27.2 | -26.5 | -8.07 |
| Depreciation and amortization | 1.13 | 1.4 | 1.93 | |||
| Stock-based compensation | 38.4 | 52.9 | 68.1 | |||
| Deferred income tax | -0.92 | |||||
| Change in receivables | -4.89 | -7.79 | -5.94 | |||
| Change in payables | 0.1 | 0.8 | -0.21 | |||
| Cash from operations | -1.6 | 1.68 | 6 | 19 | 48.7 | 65.9 |
| Capital expenditures | -0.02 | -0.17 | -0.63 | -1.05 | -1.1 | |
| Cash from investing | -0.02 | -1.27 | -9.05 | -6.63 | 3.81 | -13.6 |
| Debt issued | 0.25 | 0 | ||||
| Stock issued | 0.5 | 6.28 | 2.17 | |||
| Share buybacks | -36.3 | -39.4 | ||||
| Dividends paid | -0.02 | -0.34 | ||||
| Cash from financing | 22.9 | 7.27 | -7.85 | -3.06 | -33.1 | -40.2 |
| Exchange rate effect | -0.14 | 0.18 | 0.1 | 0.04 | 0.41 | 0 |
| Net change in cash | 9.28 | 19.4 | 12.1 | |||
| Free cash flow | -1.62 | 1.51 | 18.3 | 47.7 | 64.8 | |
| Income taxes paid | 0.05 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 8.4% | Gross profit / revenue. |
| Operating margin | -0.5% | Operating income / revenue. |
| EBITDA margin | -0.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -0.4% | Pre-tax income / revenue. |
| Net margin | -0.4% | Net income / revenue. |
| FCF margin | 3.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 3.3% | Cash from operations / revenue. |
| Return on equity (ROE) | -19.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -7.6% | Net income / average total assets. |
| Return on invested capital (ROIC) | -53.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 0.9% | Research and development expense / revenue. |
| Stock-based pay / revenue | 3.5% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.1% | Capital expenditures / revenue. |
| D&A / revenue | 0.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 55.7% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 72.8% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 160.0% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 44.4% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 73.1% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 138.3% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 35.3% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 122.4% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 35.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 60.8% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 32.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 53.9% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 46.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 42.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 42.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 15.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.41x | Current assets / current liabilities. |
| Quick ratio | 0.93x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.66x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 59.3% | Total liabilities / total assets. |
| Working capital | $30.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 10.4% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $38.5M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 18.4x | Revenue / average total assets. |
| Fixed asset turnover | 861x | Revenue / average property, plant and equipment. |
| Receivables turnover | 114x | Revenue / average receivables. |
| Days sales outstanding | 3 days | 365 x average receivables / revenue. |
| Days payables | 0 days | 365 x average accounts payable / cost of revenue. |
| Capex / operating cash flow | 1.7% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.04 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$0.04 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $8.95 | Revenue / diluted weighted shares. |
| FCF per share | $0.29 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.30 | Cash from operations / diluted weighted shares. |
| Book value per share | $0.25 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $0.18 | Tangible book value / shares outstanding. |
| Cash per share | $0.24 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 60.7% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $3.60B | Share price x shares outstanding. |
| Enterprise value | $3.55B | Market cap + total debt - cash - short-term investments. |
| P/S | 1.83x | Market cap / revenue. |
| P/B | 69.7x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 93.5x | Market cap / tangible book value, when positive. |
| P/FCF | 55.6x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 54.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.80x | Enterprise value / revenue. |
| EV/FCF | 54.8x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 1.8% | Free cash flow / market cap. |
| Earnings yield | -0.2% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 1.1% | (Dividends paid + share buybacks) / market cap. |
What was Real Brokerage Inc's revenue in fiscal 2025?
Real Brokerage Inc reported revenue of $1.97B for fiscal 2025, 55.7% higher than the year before.
Was Real Brokerage Inc profitable in fiscal 2025?
No. It reported a net loss of $8.1M.
How much free cash flow did Real Brokerage Inc generate in fiscal 2025?
Cash from operations of $65.9M minus capital expenditures of $1.1M left free cash flow of $64.8M.